Ledger.Open graph →
SEC Form D · filed July 5, 2023

Oric Pharmaceuticals, Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jacob M. Chacko · South San Francisco, CAExec · DirectorAngie L. You · South San Francisco, CADirectorDominic M. Piscitelli · South San Francisco, CAExecPratik M. Multani · South San Francisco, CAExecSteve L. Hoerter · South San Francisco, CADirectorRichard M. Heyman · South San Francisco, CADirectorLori L. Kunkel · South San Francisco, CADirectorMardi M. Dier · South San Francisco, CADirectorSteve L. Hoerter · South San Francisco, CADirectorAngie L. You · South San Francisco, CADirectorJacob M. Chacko · South San Francisco, CAExec · DirectorMardi M. Dier · South San Francisco, CADirectorLori L. Kunkel · South San Francisco, CADirectorDominic M. Piscitelli · South San Francisco, CAExecPratik M. Multani · South San Francisco, CAExecRichard M. Heyman · South San Francisco, CADirectorMikael G. Walther · Stockholm, V7DirectorSarah G. Smith · Stockholm, V7DirectorLise Kaae · Stockholm, V7DirectorSebastian Siemiatkowski · Stockholm, V7Exec · DirectorRoger Ferguson Jr · Stockholm, V7DirectorOmid Kordestani · Stockholm, V7DirectorMichael Moritz · Stockholm, V7ExecJoseph Ransdell · Chicago, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗